Nebicard-LN 5mg 10 Tablets

babies: nil. lactating mothers: it is contraindicated in lactating mothers due to studies that have shown evidence of medicine in breast milk.
it causes toxicity to the baby. pregnancy: it is contraindicated in pregnancy.
seek doctor’s advice. driving: it may cause dizziness.
so, use medication with caution. alcohol: it may cause changes in heart rate, dizziness and drowsiness.
use medication with caution. kidney: cilnidipine and nebivolol tablets should be used with caution in patients with kidney disease.
you may require a dosage adjustment and regular monitoring of kidney function. seek a doctor’s advice before using this medication.
liver: cilnidipine and nebivolol tablets should be used with caution in patients with liver disease. you may require a dosage adjustment and regular monitoring of liver function.
.

Nausea Dizziness Headache Bradycardia Chest pain Dyspnea Peripheral edema Hypercholesterolemia Paresthesia .

NEBICARD LN tablet is combination of two medicines clinidipine and nebivolol. nebivolol is a beta-blocker that works specifically on the heart to slow it down, and cilnidipine is a calcium channel blocker that works by relaxing blood vessels.
they work together to make the heart more efficient at pumping blood throughout the body..

If you miss a dose of NEBICARD LN, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• NEBICARD LN needs to be taken as directed by your physician • alcohol consumption needs to be avoided while on this medication as it may lead to changes in pulse rate, dizziness and drowsiness • inform your doctor if you are pregnant or intend to be pregnant as it may cause harmful effects to the baby • do not abruptly discontinue the medication without first consulting your doctor, as this can result in increased blood pressure.

serious • clinidipine and nebivolol + albuterol: concurrent use leads to decreased efficacy of albuterol and also cause severe bronchospasm in asthma patients • clinidipine and nebivolol + bupropion: concurrent use leads to increase plasma concentrations of nebivolol • clinidipine and nebivolol + ceritinib: concurrent use leads to increase risk of bradycardia monitor closely • clinidipine and nebivolol + acarbose: concurrent use leads to increase or decrease of blood glucose levels by altered glucose mechanism on acarbose • clinidipine and nebivolol + aceclofenac: concurrent use leads to increased blood pressure .